ডি০৯- ইন চিটু নিঅ'প্লাজম

A multicentric, double-blind, randomized, placebo-controlled, phase III study to evaluate the role of potentized (Tautopathy) form of chemotherapy in patients to determine the reduction in the pre-identified side effects of non-potentised chemotherapy drugs cisplatin, docetaxel, paclitaxel, carboplatin, epirubicin, gemcitabine, cyclophosphamide and adriamycin on cancer patients to enhance tolerance to chemotherapy regimen.

স্পনছৰ: Central Council for Research in Homoeopathy
CTRI, ভাৰতৰ ট্ৰায়েল ৰেজিষ্ট্ৰীত CTRI/2025/03/082132
উৎস: Clinical Trials Registry – India (CTRI), WHO ICTRP ৰ জৰিয়তে, 12 Oct 2026 ৰ তথ্য
ৰেজিষ্ট্ৰীত অন্তিম আপডেট 3 Aug 2026 · আমি 5 Nov 2026 ত পঢ়িছোঁ